NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair

Abstract: Vascular repair plays important roles in postischemic remodeling and rehabilitation in cardiovascular and cerebrovascular disease, such as stroke and myocardial infarction. Nicotinamide adenine dinucleotide (NAD), a well-known coenzyme involved in electron transport chain for generation of adenosine triphosphate, has emerged as an important controller regulating various biological signaling pathways. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for NAD biosynthesis in mammals. NAMPT may also act in a nonenzymatic manner, presumably mediated by unknown receptor(s). Rapidly accumulating data in the past decade show that NAMPT and NAMPT-controlled NAD metabolism regulate fundamental biological functions in endothelial cells, vascular smooth muscle cells, and endothelial progenitor cells. The NAD-consuming proteins, including sirtuins, poly-ADP-ribose polymerases (PARPs), and CD38, may contribute to the regulatory effects of NAMPT-NAD axis in these cells and vascular repair. This review discusses the current data regarding NAMPT and NAMPT-controlled NAD metabolism in vascular repair and the clinical potential translational application of NAMPT-related products in treatment of cardiovascular and cerebrovascular disease.

[1]  A. Uçak,et al.  The effect of serum, intestinal and peritoneal visfatin levels on early diagnosis of acute mesenteric ischemia. , 2016, International angiology : a journal of the International Union of Angiology.

[2]  Yuqiang Wang,et al.  SIRT1 Protects Against Oxidative Stress‐Induced Endothelial Progenitor Cells Apoptosis by Inhibiting FOXO3a via FOXO3a Ubiquitination and Degradation , 2015, Journal of cellular physiology.

[3]  Nadia Raffaelli,et al.  Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues. , 2015, Biochimica et biophysica acta.

[4]  W. Kiess,et al.  Physiological and pathophysiological roles of NAMPT and NAD metabolism , 2015, Nature Reviews Endocrinology.

[5]  Pei Wang,et al.  Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT , 2015, Scientific Reports.

[6]  J. Auwerx,et al.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. , 2015, Cell metabolism.

[7]  Deepak Sampath,et al.  Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer. , 2015, Pharmacology & therapeutics.

[8]  Pei Wang,et al.  Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase–Nicotinamide Adenine Dinucleotide Cascade , 2015, Stroke.

[9]  C. Miao,et al.  Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase , 2015, Scientific Reports.

[10]  I. Tsai,et al.  Plasma visfatin levels are associated with major adverse cardiovascular events in patients with acute ST-elevation myocardial infarction. , 2015, Clinical and investigative medicine. Medecine clinique et experimentale.

[11]  A. Gamian,et al.  Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia , 2015, BioMed research international.

[12]  K. Tobe,et al.  SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice. , 2015, Cell metabolism.

[13]  Pei Wang,et al.  Nicotinamide Phosphoribosyltransferase Facilitates Post‐Stroke Angiogenesis , 2015, CNS neuroscience & therapeutics.

[14]  P. Koulen,et al.  Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions , 2015, Clinical ophthalmology.

[15]  L. Ren,et al.  Visfatin and oxidative stress influence endothelial progenitor cells in obese populations , 2015, Endocrine research.

[16]  A. Eisch,et al.  Chronic P7C3 treatment restores hippocampal neurogenesis , 2015, Neuroscience Letters.

[17]  Sean M. Riordan,et al.  A critical role of nicotinamide phosphoribosyltransferase in human telomerase reverse transcriptase induction by resveratrol in aortic smooth muscle cells , 2015, Oncotarget.

[18]  Mark D. Huffman,et al.  AHA Statistical Update Heart Disease and Stroke Statistics — 2012 Update A Report From the American Heart Association WRITING GROUP MEMBERS , 2010 .

[19]  D. Rossi,et al.  Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. , 2015, Blood.

[20]  Yong-Qiang Wang,et al.  Serum and Vitreous Levels of Visfatin in Patients with Diabetic Retinopathy , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[21]  E. Wagner,et al.  Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. , 2014, Cancer cell.

[22]  S. Jaffrey,et al.  Activation of SIRT3 by the NAD⁺ precursor nicotinamide riboside protects from noise-induced hearing loss. , 2014, Cell metabolism.

[23]  J. Mehta,et al.  Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors. , 2014, Cardiovascular research.

[24]  N. Borradaile,et al.  Niacin receptor activation improves human microvascular endothelial cell angiogenic function during lipotoxicity. , 2014, Atherosclerosis.

[25]  A. Ballestrero,et al.  Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity* , 2014, The Journal of Biological Chemistry.

[26]  S. McKnight,et al.  P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage , 2014, Cell.

[27]  Lanfang Li,et al.  Loss of Sirt3 Limits Bone Marrow Cell-Mediated Angiogenesis and Cardiac Repair in Post-Myocardial Infarction , 2014, PloS one.

[28]  M. Gollasch,et al.  Perivascular Adipose Tissue, Potassium Channels, and Vascular Dysfunction , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[29]  L. Guarente,et al.  NAD+ and sirtuins in aging and disease. , 2014, Trends in cell biology.

[30]  Q. Kong,et al.  Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease. , 2014, Singapore medical journal.

[31]  G. Dimitriadis,et al.  Serum levels of novel adipokines in patients with acute ischemic stroke: Potential contribution to diagnosis and prognosis , 2014, Peptides.

[32]  D. Su,et al.  ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia , 2014, Autophagy.

[33]  J. Sadoshima,et al.  Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion , 2014, PloS one.

[34]  C. Miao,et al.  Extracellular Visfatin has Nicotinamide Phosphoribosyltransferase Enzymatic Activity and is Neuroprotective Against Ischemic Injury , 2014, CNS neuroscience & therapeutics.

[35]  J. Zigman,et al.  The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis , 2014, Molecular Psychiatry.

[36]  P. Pelicci,et al.  Diabetes Causes Bone Marrow Autonomic Neuropathy and Impairs Stem Cell Mobilization via Dysregulated p66Shc and Sirt1 , 2014, Diabetes.

[37]  Pei-Hsi Wang,et al.  Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[38]  Bhaskar Ponugoti,et al.  FOXO1 Promotes Wound Healing Through the Upregulation of TGF[beta]1 and Prevention of Oxidative Stress , 2013 .

[39]  Bhaskar Ponugoti,et al.  FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress , 2013, The Journal of cell biology.

[40]  M. Simons,et al.  Endothelial Cell–Dependent Regulation of Arteriogenesis , 2013, Circulation research.

[41]  B. Lévy,et al.  Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. , 2013, Physiological reviews.

[42]  N. Munshi,et al.  Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity. , 2013, Blood.

[43]  Yulin Li,et al.  Nampt expression increases during osteogenic differentiation of multi- and omnipotent progenitors. , 2013, Biochemical and biophysical research communications.

[44]  Lin Jiang,et al.  Prognostic significance of plasma visfatin levels in patients with ischemic stroke , 2013, Peptides.

[45]  M. Paulsson,et al.  PECAM1+/Sca1+/CD38+ Vascular Cells Transform into Myofibroblast-Like Cells in Skin Wound Repair , 2013, PloS one.

[46]  J. Erusalimsky,et al.  SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence , 2012, Cardiovascular research.

[47]  J. Pickering,et al.  Intrinsic directionality of migrating vascular smooth muscle cells is regulated by NAD+ biosynthesis , 2012, Journal of Cell Science.

[48]  M. Hosseinzadeh‐Attar,et al.  Elevated serum visfatin levels in patients with acute myocardial infarction. , 2012, Archives of Iranian medicine.

[49]  M. Xie,et al.  SIRT1 Regulates Endothelial Notch Signaling in Lung Cancer , 2012, PloS one.

[50]  L. Ren,et al.  Effect of visfatin on the function of endothelial progenitor cells in high-fat-fed obese rats and investigation of its mechanism of action. , 2012, International journal of molecular medicine.

[51]  P. Aukrust,et al.  Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. , 2012, Annual review of nutrition.

[52]  Jean-Baptiste Michel,et al.  The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. , 2012, Cardiovascular research.

[53]  W. Kraus,et al.  New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs , 2012, Nature Reviews Molecular Cell Biology.

[54]  J. Auwerx,et al.  The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. , 2012, Cell metabolism.

[55]  M. Trebak,et al.  Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes Mellitus , 2012, Hypertension.

[56]  A. Karsan,et al.  Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling , 2012, Proceedings of the National Academy of Sciences.

[57]  E. Mazzon,et al.  The NAMPT inhibitor FK866 reverts the damage in spinal cord injury , 2012, Journal of Neuroinflammation.

[58]  Hyun-Joo Park,et al.  Upregulation of thromboxane synthase mediates visfatin-induced interleukin-8 expression and angiogenic activity in endothelial cells. , 2012, Biochemical and biophysical research communications.

[59]  C. Miao,et al.  The role of perivascular adipose tissue in vascular smooth muscle cell growth , 2012, British journal of pharmacology.

[60]  D. Su,et al.  Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia , 2012, Autophagy.

[61]  P. Vanhoutte,et al.  Visfatin and Cardio–Cerebro–Vascular Disease , 2012, Journal of cardiovascular pharmacology.

[62]  I. Tsai,et al.  Interpretation of elevated plasma visfatin concentrations in patients with ST-elevation myocardial infarction. , 2012, Cytokine.

[63]  T. Romacho,et al.  Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity , 2011, PloS one.

[64]  Yulin Li,et al.  Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: A possible cause for reduced osteogenesis and increased adipogenesis in older individuals , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[65]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[66]  F. Dequiedt,et al.  Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase , 2011, Nature.

[67]  J. Y. Kim,et al.  Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway. , 2011, Biochimica et biophysica acta.

[68]  C. Miao,et al.  A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase. , 2011, Analytical biochemistry.

[69]  R. Kageyama,et al.  Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis. , 2011, Cardiovascular research.

[70]  B. Viollet,et al.  Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1‐dependent adenosine monophosphate–activated kinase pathway , 2011, Annals of neurology.

[71]  D. Brat,et al.  Discovery of a Proneurogenic, Neuroprotective Chemical , 2010, Cell.

[72]  J. Auwerx,et al.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. , 2010, Endocrine reviews.

[73]  R. Bristow,et al.  Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma , 2010, Clinical Cancer Research.

[74]  N. Borradaile,et al.  Polyploidy impairs human aortic endothelial cell function and is prevented by nicotinamide phosphoribosyltransferase. , 2010, American journal of physiology. Cell physiology.

[75]  A. Ballestrero,et al.  Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE , 2009, PloS one.

[76]  H. Wee,et al.  Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis. , 2009, Biochimica et biophysica acta.

[77]  J. Pickering,et al.  SIRT1 markedly extends replicative lifespan if the NAD+ salvage pathway is enhanced , 2009, FEBS letters.

[78]  Shyi-Jang Shin,et al.  Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke. , 2009, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[79]  Dan Shao,et al.  Nicotinamide Phosphoribosyltransferase Regulates Cell Survival Through NAD+ Synthesis in Cardiac Myocytes , 2009, Circulation research.

[80]  H. Randeva,et al.  Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. , 2009, Atherosclerosis.

[81]  M. Okada,et al.  Visfatin causes endothelium-dependent relaxation in isolated blood vessels. , 2009, Biochemical and biophysical research communications.

[82]  M. Al-Omran,et al.  Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. , 2009, American journal of physiology. Endocrinology and metabolism.

[83]  P. Sassone-Corsi,et al.  Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1 , 2009, Science.

[84]  J. Takahashi,et al.  Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis , 2009, Science.

[85]  M. Harmsen,et al.  Endothelial progenitor cell-based neovascularization: implications for therapy. , 2009, Trends in molecular medicine.

[86]  Wieland Kiess,et al.  Nampt: linking NAD biology, metabolism and cancer , 2009, Trends in Endocrinology & Metabolism.

[87]  N. Borradaile,et al.  Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment , 2009, Aging cell.

[88]  Shan Wang,et al.  Involvement of dimethylarginine dimethylaminohydrolase‐2 in visfatin‐enhanced angiogenic function of endothelial cells , 2009, Diabetes/metabolism research and reviews.

[89]  F. Koch-Nolte,et al.  Emerging Roles of NAD+ and Its Metabolites in Cell Signaling , 2009, Science Signaling.

[90]  H. Wee,et al.  Upregulation of fibroblast growth factor-2 by visfatin that promotes endothelial angiogenesis. , 2009, Biochemical and biophysical research communications.

[91]  D. Su,et al.  Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. , 2009, Cardiovascular research.

[92]  Véronique Kruys,et al.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner , 2009, Nature Medicine.

[93]  E. Chini.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions. , 2009, Current pharmaceutical design.

[94]  Yuan Zhang,et al.  Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism* , 2008, Journal of Biological Chemistry.

[95]  E. Hoffman,et al.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. , 2008, Developmental cell.

[96]  B. Lévy,et al.  Post-ischaemic neovascularization and inflammation. , 2008, Cardiovascular research.

[97]  H. Randeva,et al.  Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. , 2008, Cardiovascular research.

[98]  D. Yellon,et al.  The novel adipocytokine visfatin exerts direct cardioprotective effects , 2008, Journal of cellular and molecular medicine.

[99]  B. Berk,et al.  PARP-1 Inhibition Prevents Oxidative and Nitrosative Stress–Induced Endothelial Cell Death via Transactivation of the VEGF Receptor 2 , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[100]  J. Milbrandt,et al.  Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. , 2007, Cell metabolism.

[101]  F. Alt,et al.  SIRT1 controls endothelial angiogenic functions during vascular growth. , 2007, Genes & development.

[102]  Dudley Lamming,et al.  Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival , 2007, Cell.

[103]  A. Churchman,et al.  Adventitial growth factor signalling and vascular remodelling: potential of perivascular gene transfer from the outside-in. , 2007, Cardiovascular research.

[104]  Kyu-Won Kim,et al.  Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. , 2007, Biochemical and biophysical research communications.

[105]  S. Cregan,et al.  Extension of Human Cell Lifespan by Nicotinamide Phosphoribosyltransferase* , 2007, Journal of Biological Chemistry.

[106]  Y. Aso,et al.  Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[107]  A. Bernkop‐Schnürch,et al.  Strategies to improve plasma half life time of peptide and protein drugs , 2006, Amino Acids.

[108]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[109]  J. Pickering,et al.  Pre–B-Cell Colony–Enhancing Factor Regulates NAD+-Dependent Protein Deacetylase Activity and Promotes Vascular Smooth Muscle Cell Maturation , 2005, Circulation research.

[110]  C. Brenner,et al.  Discoveries of Nicotinamide Riboside as a Nutrient and Conserved NRK Genes Establish a Preiss-Handler Independent Route to NAD+ in Fungi and Humans , 2004, Cell.

[111]  J. Marshall,et al.  Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. , 2004, The Journal of clinical investigation.

[112]  Tadhg P Begley,et al.  NAD biosynthesis: identification of the tryptophan to quinolinate pathway in bacteria. , 2003, Chemistry & biology.

[113]  P. Rich.  The molecular machinery of Keilin's respiratory chain. , 2003, Biochemical Society transactions.

[114]  D. Gigot,et al.  Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.

[115]  G. Magni,et al.  Enzymology of NAD+ synthesis. , 1999, Advances in enzymology and related areas of molecular biology.

[116]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[117]  I McNiece,et al.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.

[118]  W. Schulte,et al.  Cerebral ischemia : molecular and cellular pathophysiology , 1999 .

[119]  P. Handler,et al.  Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. , 1958, The Journal of biological chemistry.

[120]  P. Handler,et al.  Biosynthesis of diphosphopyridine nucleotide. II. Enzymatic aspects. , 1958, The Journal of biological chemistry.